ID: 20	RANK: 55	SCORE: 15.7261



<DOC>
<DOCNO> FR940525-2-00054 </DOCNO>
<PARENT> FR940525-2-00044 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Opportunity For A License: Whole Chromosome Painting Probes (WCP Probes) and Band-Region Specific Painting Probes
(Micro-FISH Probes) Developed by Dr. Paul Meltzer and Dr. Jeffrey Trent, National Center for Human Genome Research
</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 National Institutes of Health, Public Health Service, DHHS.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The National Institutes of Health seeks non-exclusive biological materials licensees to commercialize Whole Chromosome
Painting Probes (WCP probes) and Region Specific Painting Probes (Micro-FISH probes) generated by chromosome microdissection
and amplification of specific regions, and labelled for Fluorescent in situ Hybridization (FISH). The probes can
be hybridized to normal metaphase chromosomes and used as either diagnostic reagents for identification of chromosomal
abnormalities or as research reagents to further study various cancers and hereditary diseases. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
WCP probes for all human chromosomes are being generated using a universal primer. The probes are significantly superior
to current probes due to greater sensitivity and selectivity. The subject invention allows generation of probes
for the acrocentric chromosomes (13,14,15,21 and 22) by elimination of shared ribosomal elements between these
chromosomes. 
<!-- PJG 0012 frnewline -->
While numerous whole chromosome painting probes are presently available, most have technical limitations. Most
frequently, hybridization to portions of the target chromosome is incomplete because of gaps in the sequence. Additionally,
in many cases flow-sorted chromosomes in rodent backgrounds invariably transfer some sequences which make these
unusable for research analysis with somatic cell hybrids. 
<!-- PJG 0012 frnewline -->
The WCP and Micro-FISH probes address these problems. The probes can be used to analyze complex chromosome rearrangements
in a variety of malignancies, clearly identifying chromosome rearrangements which could not be detected by conventional
banding analysis. The probes can also be generated to span translocation breakpoints and identify interstitial
deletions, both of which would confound conventionally created whole chromosome painting probes. 
<!-- PJG 0012 frnewline -->
Beyond improvements in specificity and sensitivity, probes created by the micro-FISH method eliminate the microchemical
steps required by other methods by using a DNA oligonucleotide primer to directly prime DNA synthesis at intervals
along the microdissected DNA template. Accordingly, the procedure for probe preparation is dramatically simplified
and accelerated, and since the major losses associated with the microchemical process are largely eliminated, the
probes emit a stronger and more uniform signal intensity than other commonly available probes. 
<!-- PJG 0012 frnewline -->
NIH is the assignee of the rights for this technology developed by Drs. Trent and Meltzer of the National Center for
Human Genome Research. The laboratory at the National Center for Human Genome Research will make dissected chromosomal
biological material available for probe manufacture, through a nonexclusive biological materials license agreement.

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Licensing information may be obtained by contacting Carol Lavrich, Technology Licensing Specialist, National
Institutes of Health, Office of Technology Transfer, 6011 Executive Boulevard, Suite 325, Rockville, Maryland
20852&hyph;3804 (telephone 301/496&hyph;7735; fax 301/402&hyph;0220). 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: May 13, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ADDRESS>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Barbara M. McGarey, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Director, 
<!-- PJG 0012 frnewline -->
Office of Technology Transfer. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;12689 Filed 5&hyph;24&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4140&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>
